↓ Skip to main content

Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures

Overview of attention for article published in Frontiers in immunology, November 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
12 X users
patent
1 patent
video
1 YouTube creator

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures
Published in
Frontiers in immunology, November 2021
DOI 10.3389/fimmu.2021.662223
Pubmed ID
Authors

Garth E. Ringheim, Matthew Wampole, Kinsi Oberoi

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 112 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 13%
Student > Ph. D. Student 10 9%
Student > Master 10 9%
Student > Postgraduate 5 4%
Student > Doctoral Student 5 4%
Other 19 17%
Unknown 48 43%
Readers by discipline Count As %
Medicine and Dentistry 21 19%
Biochemistry, Genetics and Molecular Biology 9 8%
Neuroscience 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Agricultural and Biological Sciences 5 4%
Other 17 15%
Unknown 49 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2024.
All research outputs
#4,445,585
of 26,196,613 outputs
Outputs from Frontiers in immunology
#4,889
of 32,872 outputs
Outputs of similar age
#91,225
of 448,805 outputs
Outputs of similar age from Frontiers in immunology
#260
of 1,527 outputs
Altmetric has tracked 26,196,613 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,872 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,805 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 1,527 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.